Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00718094 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis
A Phase 2 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00718094 is a Phase 2 study that has completed, run by University of Louisville. The registered enrollment target is 20 participants.
The verdict
NCT00718094, a Phase 2 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Green tea consists of several components, with most research focusing on the polyphenol fraction. The polyphenol fraction(-)-epigallocatechin-3-gallate (EGCG)has been studied extensively as an anti-inflammatory agent as well as a preventative agent for cancer. It has been shown to effectively reduce the inflammation associated with animal models of inflammatory bowel disease. This clinical trial will determine the ability of EGCG, in the form of Polyphenon E®, to treat patients with mild to moderately severe ulcerative colitis.
Interventions
- DRUG Placebo Oral Tablet
- DRUG Polyphenon E®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00718094
The ClinicalTrials.gov registry entry for NCT00718094 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT00718094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00718094 about?
NCT00718094 is a clinical study titled "Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis". Green tea consists of several components, with most research focusing on the polyphenol fraction. The polyphenol fraction(-)-epigallocatechin-3-gallate (EGCG)has been studied extensively as an anti-inflammatory agent as well as a preventative agent for cancer. It has been shown to effectively reduce...
What is the current status of trial NCT00718094?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2008-03. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00718094?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Polyphenon E® (DRUG).
Who is sponsoring clinical trial NCT00718094?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.